1. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom;
2. Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom;
3. Department of Haemato-Oncology, The Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom;
4. Department of Haematology, Cambridge University Hospitals National Health Service Foundation Trust, Addenbrooke’s Hospital, Cambridge, United Kingdom; and
5. Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom